These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27853178)

  • 1. Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma.
    Ouyang FZ; Wu RQ; Wei Y; Liu RX; Yang D; Xiao X; Zheng L; Li B; Lao XM; Kuang DM
    Nat Commun; 2016 Nov; 7():13453. PubMed ID: 27853178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine epithelial expression of the tumor necrosis factor superfamily: a strategy for immune privilege during pregnancy in a true epitheliochorial placentation species.
    Yoo I; Kye YC; Han J; Kim M; Lee S; Jung W; Hong M; Park TS; Yun CH; Ka H
    Biol Reprod; 2020 Apr; 102(4):828-842. PubMed ID: 31901087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
    Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
    Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine (C-X-C motif) receptor 3-positive B cells link interleukin-17 inflammation to protumorigenic macrophage polarization in human hepatocellular carcinoma.
    Liu RX; Wei Y; Zeng QH; Chan KW; Xiao X; Zhao XY; Chen MM; Ouyang FZ; Chen DP; Zheng L; Lao XM; Kuang DM
    Hepatology; 2015 Dec; 62(6):1779-90. PubMed ID: 26235097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma.
    Liu J; Sun B; Guo K; Yang Z; Zhao Y; Gao M; Yin Z; Jiang K; Dong C; Gao Z; Ye M; Liu J; Wang L
    Cancer Gene Ther; 2022 Dec; 29(12):1951-1960. PubMed ID: 35902729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.
    Han Q; Wang Y; Pang M; Zhang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):156. PubMed ID: 29115974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17-educated monocytes suppress cytotoxic T-cell function through B7-H1 in hepatocellular carcinoma patients.
    Zhao Q; Xiao X; Wu Y; Wei Y; Zhu LY; Zhou J; Kuang DM
    Eur J Immunol; 2011 Aug; 41(8):2314-22. PubMed ID: 21674477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH; Mei MH; Fei R; Liu F; Wang JH; Liao WJ; Qin LL; Wei L; Chen HS
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor antigen pulsed dendritic cells enhance the cytolytic activity of tumor infiltrating lymphocytes in human hepatocellular cancer.
    Friedl J; Stift A; Paolini P; Roth E; Steger GG; Mader R; Jakesz R; Gnant MF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):477-86. PubMed ID: 11155819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression.
    Li Z; Luo H; Li C; Huo X; Yan C; Huang X; Al-Haddawi M; Mathavan S; Gong Z
    Int J Cancer; 2014 Oct; 135(7):1564-73. PubMed ID: 24550086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function.
    Hu CE; Gan J; Zhang RD; Cheng YR; Huang GJ
    Scand J Gastroenterol; 2011 Feb; 46(2):156-64. PubMed ID: 20822377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma.
    Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR
    Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.
    Han Y; Wu Y; Yang C; Huang J; Guo Y; Liu L; Chen P; Wu D; Liu J; Li J; Zhou X; Hou J
    J Transl Med; 2017 Mar; 15(1):64. PubMed ID: 28330473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.
    Han Y; Chen Z; Yang Y; Jiang Z; Gu Y; Liu Y; Lin C; Pan Z; Yu Y; Jiang M; Zhou W; Cao X
    Hepatology; 2014 Feb; 59(2):567-79. PubMed ID: 23960017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
    Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
    J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
    Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
    Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR5
    Jin Y; Lang C; Tang J; Geng J; Song HK; Sun Z; Wang J
    Int Immunopharmacol; 2017 Dec; 53():42-48. PubMed ID: 29032029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
    Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.